TLCR Reading Tools
How to cite item
The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{32486}, author = {Wang, L., He, Z., Yang, S., Tang, H., Wu, Y., Li, S., Han, B., Li, K., Zhang, L., Shi, J., Wang, Z., Cheng, Y., He, J., Shi, Y., Chen, W., Luo, Y., Wu, L., Wang, X., Nan, K., Jin, F., Dong, J., Li, B., Sun, Y., Wang, Q.}, title = {The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial}, journal = {Translational Lung Cancer Research}, volume = {8}, number = {5}, year = {2019}, url = {https://tlcr.amegroups.org/article/view/32486} }